Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
- 作者Cornel Pater
- 卷第6卷
- 期第1期
- 印刷ISSN1745-6215
- 文件大小702.84KB
- 发表时间2005-12
- DOI10.1186/1468-6708-6-1
Current trends in the cardiovascular clinical trial arena (I)Cornel Pater · 2004
The current status of primary prevention in coronary heart diseaseCornel Pater · 2001
Hyperuricemia and Hypertension — A Causal Relationship Ignored For All Too LongPater, Cornel · Current Hypertension Reviews · 2011
Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)Cornel Pater · 2004
The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)Cornel Pater · 2005
Methodological considerations in the design of trials for safety assessment of new drugs and chemical entitiesCornel Pater · 2005
Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement – is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I)Cornel Pater · 2005